Kymera Therapeutics, Inc.
KYMR
46 insider filings · Latest: Jun 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Jul 1 8:58 PM | NOAH GOODMAN | Proposed Sale | 3,389 | $114.67 | $388.6K | — | View → |
| Jun 29, 2026 | Jun 30 9:32 PM | Bruce BoothDirector | Sale | 31,283 | $109.48 | $3.4M | 461,794(I) | View → |
| Jun 29, 2026 | Jun 30 9:30 PM | Bruce BoothDirector | Sale | 45,367 | $107.06 | $4.9M | 466,077(I) | View → |
| Jun 26, 2026 | Jun 30 9:30 PM | Bruce BoothDirector | Sale | 467,878 | $110.29 | $51.6M | 472,267(I) | View → |
| Jun 30, 2026 | Jun 30 8:32 PM | BRUCE N. JACOBS | Proposed Sale | 77,109 | $109.32 | $8.4M | — | View → |
| Jun 29, 2026 | Jun 29 9:51 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 10,473 | $108.12 | $1.1M | — | View → |
| Jun 29, 2026 | Jun 29 9:51 PM | Atlas Venture Fund X, LP | Proposed Sale | 66,177 | $108.12 | $7.2M | — | View → |
| Jun 26, 2026 | Jun 26 10:48 PM | P/Il L Bvf PartnersDirector, Other | Sale | 1,630,658 | $106.50 | $173.7M | 78,787(I) | View → |
| Jun 26, 2026 | Jun 26 10:13 PM | BVF PARTNERS L P/IL | Proposed Sale | 1,630,658 | $116.46 | $189.9M | — | View → |
| Jun 26, 2026 | Jun 26 8:52 PM | Atlas Venture Fund X, LP | Proposed Sale | 410,427 | $116.46 | $47.8M | — | View → |
| Jun 26, 2026 | Jun 26 8:51 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 57,451 | $116.46 | $6.7M | — | View → |
| Jun 25, 2026 | Jun 26 1:56 AM | Bruce BoothDirector | Sale | 285,684 | $121.86 | $34.8M | 529,718(I) | View → |
| Jun 25, 2026 | Jun 26 1:55 AM | Bruce BoothDirector | Sale | 262,637 | $115.39 | $30.3M | 564,668(I) | View → |
| Jun 24, 2026 | Jun 26 1:55 AM | Bruce BoothDirector | Sale | 134,720 | $100.51 | $13.5M | 597,047(I) | View → |
| Jun 23, 2026 | Jun 26 1:55 AM | Bruce BoothDirector | Sale | 1,408 | $99.98 | $140.8K | 613,589(I) | View → |
| Jun 25, 2026 | Jun 25 10:00 PM | Noah GoodmanChief Business Officer | Sale | 5,000 | $114.00 | $570.0K | 50,195.438(D) | View → |
| Jun 25, 2026 | Jun 25 9:26 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 67,329 | $99.87 | $6.7M | — | View → |
| Jun 25, 2026 | Jun 25 9:25 PM | Atlas Venture Fund X, LP | Proposed Sale | 480,992 | $99.87 | $48.0M | — | View → |
| Jun 25, 2026 | Jun 25 8:27 PM | NOAH GOODMAN | Proposed Sale | 5,000 | $99.87 | $499.4K | — | View → |
| Jun 24, 2026 | Jun 24 9:30 PM | Atlas Venture Fund X, LP | Proposed Sale | 118,178 | $98.25 | $11.6M | — | View → |
Page 1 of 7
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Jan 20 11:30 PM | Pamela EspositoDirector | Option Exercise | 5,500 | $49.10 | 5,000(D) | View → |
| Dec 31, 2025 | Dec 31 10:23 PM | Nello MainolfiDirector, Chief Executive Officer | Option Exercise | 30,000 | $2.08 | 275,559(D) | View → |
← Previous
Page 3 of 3